Viewing Study NCT00110695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-20 @ 1:33 PM
Study NCT ID: NCT00110695
Status: COMPLETED
Last Update Posted: 2010-03-26
First Post: 2005-05-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer
Sponsor: NSABP Foundation Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSABP View
None Abraxis View
None Abraxane View
None Locally advanced breast cancer View
None Fluorouracil View
None Epirubicin View
None Cyclophosphamide View
None FEC View